Article
Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
Hepato-gastroenterology - 1 Jan 2000
Yasa Mehmet Hadi, Bolaman Zahit, Yukselen Vahit, Kadikoylu Gurhan, Karaoglul Ali Onder, Batun Sabri
Abstract excerpt
BACKGROUND/AIMS: Patients with inflammatory bowel disease (IBD) have an increased risk for thromboembolic complications. We investigated the incidence of factor V Leiden G1691A, methylene tetrahydrofolate reductase (MTHFR) C677T, and prothrombin G20210A mutation in 27 Turkish IBD patients with no history of thromboembolic disease. METHODOLOGY: Twenty-seven patients, 22 with ulcerative colitis (UC) and 5 with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.